Literature DB >> 17279013

Possible increase of the neurotoxicity of vincristine by the concurrent use of posaconazole in a young adult with leukemia.

Elpis Mantadakis, George Amoiridis, Anna Kondi, Maria Kalmanti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17279013     DOI: 10.1097/MPH.0b013e318030d289

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


× No keyword cloud information.
  5 in total

Review 1.  Adverse interactions between antifungal azoles and vincristine: review and analysis of cases.

Authors:  Brad Moriyama; Stacey A Henning; Janice Leung; Oluwaseun Falade-Nwulia; Paul Jarosinski; Scott R Penzak; Thomas J Walsh
Journal:  Mycoses       Date:  2011-11-29       Impact factor: 4.377

Review 2.  Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health.

Authors:  Kirsten K Ness; Saro H Armenian; Nina Kadan-Lottick; James G Gurney
Journal:  Expert Rev Hematol       Date:  2011-04       Impact factor: 2.929

3.  Posaconazole-vincristine coadministration triggers seizure in a young female adult: a case report.

Authors:  Dalia A Hamdy; Hager El-Geed; Samah El-Salem; Manal Zaidan
Journal:  Case Rep Hematol       Date:  2012-03-14

4.  Prolonged vincristine toxicity induced by concurrent posaconazole in a child with T-cell acute lymphoblastic leukemia.

Authors:  Samin Alavi; Maryam Ebadi
Journal:  Iran J Med Sci       Date:  2013-06

5.  Hyperlipidemia Alters the Pharmacokinetics of Posaconazole and Vincristine Upon Co-Administration in Rats.

Authors:  Hadeel A Khalil; Mohammed A W ElKhatib; Tarek S Belal; Ahmed F El-Yazbi; Dalia A Hamdy
Journal:  Drugs R D       Date:  2017-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.